QR Kod

Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)

<b>Background</b>: Cannabidiol (CBD) is an approved treatment for childhood epilepsies and a candidate treatment for several other CNS disorders. However, it has poor oral bioavailability. We investigated the effect of a novel lipid formulation on its absorption in humans and on its tissue distribut...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Edward Chesney, Ndabezinhle Mazibuko, Dominic Oliver, Amedeo Minichino, Ayşe Doğa Lamper, Lucy Chester, Thomas J. Reilly, Millie Lloyd, Matilda Kråkström, Alex M. Dickens, Matej Orešič, Eric Lynch, Gregory Stoloff, Mitul A. Mehta, Philip McGuire
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI AG 2024-12-01
Seri Bilgileri:Pharmaceutics
Konular:
CBD
cannabidiol
pharmacokinetics
bioavailability
formulation
Online Erişim:https://www.mdpi.com/1999-4923/16/12/1537
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller